Carboplatin induces apoptotic cell death through downregulation of constitutively active nuclear factor-κB in human HPV-18 E6-positive HEp-2 cells

Biochemical and Biophysical Research Communications

Volumn 318, Issue 2, 2004, Pages 346-353

  Singh, Sandeep ^a   Bhat, Manoj Kumar ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

Bcl 2; Carboplatin; HPV 18 E6; NF B

Indexed keywords

CARBOPLATIN; CURCUMIN; DNA; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REPRESSOR PROTEIN; SYNAPTOTAGMIN;

APOPTOSIS; ARTICLE; BIOACCUMULATION; CELL DEATH; CELL NUCLEUS; CELL SURVIVAL; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; DRUG INHIBITION; GENETIC TRANSFECTION; HEP 2 CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STIMULUS; TRANSACTIVATION; WART VIRUS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARBOPLATIN; CELL DIVISION; CELL LINE, TUMOR; CELL NUCLEUS; CURCUMIN; CYTOPLASM; DNA-BINDING PROTEINS; DOWN-REGULATION; GENES, REPORTER; HUMANS; I-KAPPA B PROTEINS; NF-KAPPA B; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; REPRESSOR PROTEINS; TRANSCRIPTION FACTOR RELA; TRANSFECTION;

EID: 2142700030     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.04.037     Document Type: Article

References (22)

1. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 18:1999;6853-6866
2. Karin M. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene. 18:1999;6867-6874
3. Darnell J.E. Jr. Transcription factors as targets for cancer therapy. Nat. Rev. Cancer. 2:2002;740-749
4. Baldwin A.S. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J. Clin. Invest. 107:2001;241-246
5. Philip S., Bulbule A., Kundu G.C. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-κB-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. J. Biol. Chem. 276:2001;44926-44935
6. Heckman C.A., Mehew J.W., Boxer L.M. NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells. Oncogene. 21:2002;3898-3908
7. Hansen M.B., Nielsen S.E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods. 119:1989;203-210
8. Kurland J.F., Kodym R., Story M.D., Spurgers K.B., McDonnell T.J., Meyn R.E. NF-κB1 (p50) homodimers contribute to transcription of the bcl-2 oncogene. J. Biol. Chem. 276:2001;45380-45386
9. Chiao P.J., Na R., Niu J., Sclabas G.M., Dong Q., Curley S.A. Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells. Cancer. 15:2002;1696-1705
10. Zerbini L.F., Wang Y., Cho J.Y., Libermann T.A. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Cancer Res. 63:2003;2206-2215
11. Spitkovsky D., Hehner S.P., Hofmann T.G., Moller A., Schmitz M.L. The human papilloma virus oncoprotein E7 attenuates NF-κB activation by targeting the IκB kinase complex. J. Biol. Chem. 277:2002;25576-25582
12. Singh S., Aggarwal B.B. Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane). J. Biol. Chem. 270:1995;24995-25000
13. Brown K., Gerstberger S., Carlson L., Franzoso G., Siebenlist U. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science. 267:1995;1485-1488
14. Kucharczak J., Simmons M.J., Fan Y., Gelinas C. To be, or not to be: NF-kappaB is the answer - role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene. 22:2003;8961-8982
15. Baeuerle P.A., Baichwal V.R. NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv. Immunol. 65:1997;111-137
16. Chen Z.J., Parent L., Maniatis T. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell. 84:1996;853-862
17. Goodkin M.L., Ting A.T., Blaho J.A. NF-κB is required for apoptosis prevention during herpes simplex virus type 1 infection. J. Virol. 77:2003;7261-7280
18. Medina E., Anders D., Chhatwal G.S. Induction of NF-kappaB nuclear translocation in human respiratory epithelial cells by group A streptococci. Microb. Pathog. 33:2002;307-313
19. Rayet B., Gelinas C. Aberrant rel/NF-κB genes and activity in human cancer. Oncogene. 18:1999;6938-6947
20. Bharti A.C., Donato N., Singh S., Aggarwal B.B. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood. 101:2003;1053-1062
21. Bian X., Opipari A.W. Jr., Ratanaproeksa A.B., Boitano A.E., Lucas P.C., Castle V.P. Constitutively active NF-κB is required for the survival of S-type neuroblastoma. J. Biol. Chem. 277:2002;42144-42150
22. Feuillard J., Schuhmacher M., Kohanna S., Asso-Bonnet M., Ledeur F., Joubert-Caron R., Bissières P., Polack A., Bornkamm G.W., Raphael M. Inducible loss of NF-κB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes. Blood. 95:2000;2068-2075